skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: All three are down this morning. Any news. Are there any short reports out on any of the three companies ? RAK
Read Answer Asked by bob on September 04, 2018
Q: I have been seeing more questions on TH recently and see no reason not to begin a modest position but I wanted to compare it to two companies you have endorsed and which I own. Do you see more or less upside in TH vs RHT and COV? Could you rank these three according to growth potential and risk? To clarify, please rank 123 based on which have the most upside and 123 based on which are risky from least to most. Deduct credits as you see fit.

Thanks!
Read Answer Asked by Tim on August 22, 2018
Q: Hi,
Just noticed that TH has issued a Treasury Offering of Convertible Unsecured Senior Notes. The size of the issue is US $ 50 million, par value $100.00. They are 5 Yr cd's witha coupon of 5.75% and a converstion price of US $ 14.75 (equivalent to about Cdn $ 19.12)

Would you feel this is a good value cd, or are we better to just buy the stock directly? As always, we value your opinion.

Thanks,
Dawn
Read Answer Asked by Dawn on May 31, 2018
Q: Hello 5i, what is your opinion on theses three companies for a 2-3 year hold? Would you invest in any of those? If not, do you have a better suggestion in the small cap area? Does not have to be in pharma/life science. Thanks for the great service!
Read Answer Asked by Jean-Bernard on May 24, 2018
Q: Why would not GUD take a run at TH....both Montreal based cos. TH has 2 FDA approved drugs, one of which is life-saving and the market has not given this co a much better valuation. Plus TH has about 32 mil in cash and little debt!
Read Answer Asked by george on April 13, 2018
Q: I've enjoyed a quick run-up on TH. It now represents an 8% portfolio weight. My questions is two parts. First, could you comment on their prospects? Their earnings should be growing and they are adding a drug to their offering. As a thing trader, there could be a big run-up as the story gains traction.
Second, in a case like this where there is a quick run-up and the portfolio weighting becomes large, when is it time to trim? It seems to me that using portfolio weight as your only guide could mean missing big gains if you're early on a good company.
Read Answer Asked by Brian on March 07, 2017
Q: Can we get your opinion on TH with regards to:
- financial results announced Feb.8/17
- results of recent tests of their product
- is their a chance this company could become a portfolio changer, I mean should I average up and take this to a 3% position from 1.5%

Thanks for your great service as I would likely not heard of a company like TH without being a member
Read Answer Asked by James on February 21, 2017
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!